There's related news today oh boy; here's how it's presented on the front page of the print edition NYT:

Battle in States on Generic Copies of Biotech Drugs

Blockbuster Medicines

Lobbying May Threaten Savings in Overhaul of Health Care

By Andrew Pollack

In statehouses around the country, some of the nation’s biggest biotechnology companies are lobbying intensively to limit generic competition to their blockbuster drugs, potentially cutting into the billions of dollars in savings on drug costs contemplated in the federal health care overhaul law.

The complex drugs, made in living cells instead of chemical factories, account for roughly one-quarter of the nation’s $320 billion in spending on drugs, according to IMS Health. And that percentage is growing. They include some of the world’s best-selling drugs, like the rheumatoid arthritis and psoriasis drugs Humira and Enbrel and the cancer treatments Herceptin, Avastin and Rituxan. The drugs now cost patients — or their insurers — tens or even hundreds of thousands of dollars a year [,,,,,]

Like just one quarter of $320 billion would be nice to spend on starting improving psychiatric care, eh? But our gummints can't afford that, they need to insure that drug developers make not just fortunes but continuing huge fortunes for an exceedingly long time.....

Thanks Moat,

They went straight to Chemo first, to be followed up with a mastectomy, then radiation.

It's going to be a tough time for her little ones who'll learn first hand; their mommy will have to get sick, before she gets better.